NP / PA
Ward, Christy
Ward, Christy was paid $350K by Medicaid between Jan 2018 and Nov 2020, across 24 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 69% of everything it billed.
33Billing provider infoWARD, CHRISTY
ALAMO, TN 38001
ALAMO, TN 38001
33aNPI1952670226assigned 12/15/2011
33bProvider typeFamily Nurse Practitioner
28Total paid$350K
24GClaims13,724
24DCodes billed24
24AFirst – last monthJan 2018 – Nov 2020
Compared with peers
Next to other Family Nurse Practitioner providers in Tennessee
Rank by total paid#52 of 687
Median peer was paid$15K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,623 | $137K | |
| 2019 | 5,372 | $133K | |
| 2020 | 2,729 | $80K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 69% | 4,063 | 3,327 | $241K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 954 | 845 | $39K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.5% | 1,025 | 839 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.2% | 825 | 518 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 1,672 | 1,279 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.6% | 981 | 759 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 240 | 202 | $6K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 68 | 57 | $3K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 49 | 39 | $3K |
| 36416 | <1% | 1,305 | 991 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 241 | 185 | $1K |
| 81003 | <1% | 890 | 738 | $1K |
12 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 668 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 29 | $632.61 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 265 | $565.52 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 53 | $550.28 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 30 | $451.45 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 24 | $307.82 |
| 90756 | <1% | 16 | $257.78 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 257 | $109.53 |
| 92551 | <1% | 14 | $89.72 | |
| 99173 | <1% | 16 | $38.87 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14 | $26.54 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 25 | $0.98 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.